Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-16

Clinical Trial Update: Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating heat-killed probiotics for the prevention of necrotizing enterocolitis. The trial status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heat-killed probiotics (heat-killed probiotic preparation)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Necrotizing Enterocolitis, Enterocolitis, Necrotizing | Phase 2 | Status: UNKNOWN